How Pharma Companies Can Standardize Product Detailing
Easy E-Detailing gives a pharma company one Android workspace where every division works from the same current, approved material instead of scattered files and outdated copies. Standardizing product detailing this way means fewer version mistakes in the field and a shorter path from an approved update to what representatives actually present.
Define the approved core story
Start with the product objective, intended audience and approved evidence. Build a short sequence that explains the key message logically: context, relevant product information, supporting evidence, practical use information and required safety content. Optional pages can support deeper questions without lengthening every call.
Representatives should understand the story, not only memorize page order. Training must explain why each visual exists, what may be said and where the limits of the approved material are.
Use a consistent project structure
Create a naming convention for division, brand, campaign and version. Inside each project, use predictable categories such as core detail, evidence, dosage, safety and FAQs. The same pattern across brands reduces search time and makes training easier.
Avoid storing multiple “final” files with unclear dates. One approved source, one field version and a documented archive process are easier to govern than several informal copies shared through messaging apps.
Control versions from approval to withdrawal
- Record the approval identifier and effective date.
- Prepare the field format from that approved master.
- Run content and visual QA on the target tablet.
- Distribute through the permitted process.
- Confirm representatives can open the new version offline.
- Withdraw the previous version and document completion.
Small companies benefit especially from a simple process. A spreadsheet or controlled register can be sufficient if ownership and evidence are clear.
Train for conversation, not slide reading
Training should include short and standard call routes, likely questions, approved responses and how to navigate optional evidence. Use role-play with the actual tablet. Ask representatives to recover from a short appointment, a connectivity failure and a question outside the prepared content.
Managers should coach clarity, listening and responsible use of evidence. Slide-completion percentage is not a meaningful measure of a good doctor interaction.
Evaluate software on field realities
| Need | What to verify |
|---|---|
| Import | Actual PDF, PPT/PPTX and image compatibility with company files |
| Organization | Projects, categories, page order and fast retrieval |
| Presentation | Readable full-screen tablet view and orientation |
| Offline | Prepared pages remain available after activation |
| Continuity | Controlled backup, restore and device-change process |
| Support | Clear contact path and documented limitations |
Pilot before wider rollout
Choose a small representative group, two or three realistic brands and a defined trial period. Measure setup friction, navigation errors, offline reliability, content readability and support needs. Resolve device and training issues before expanding.
Easy E-Detailing gives MRs an Android tablet workspace for projects, categories, supported content import and full-screen viewing, and gives Managers a separate workspace to review linked MR activity, attendance and follow-ups. Compare the field features, Manager + MR plans and the complete app workflow. Pharma companies remain responsible for content approval, access policy and field governance.
Create an ownership matrix
Assign a named owner for the approved source, field-format preparation, technical QA, representative access, support and withdrawal. In a small company, one person may perform several roles, but the decisions should still be explicit. This prevents the common situation where everyone assumes someone else removed an outdated project.
Set a service expectation for field issues: what representatives should check first, where they should report a broken import and who can authorize a content change. Technical support may repair a file or device workflow, but scientific and promotional changes must return to the appropriate reviewer.
Review the process periodically using concrete evidence such as support requests, failed offline tests, version acknowledgements and training observations. Avoid collecting personal or clinical information that is not needed for the stated operational purpose.
Working through a first rollout now? The E-Detailing Implementation Checklist for Pharma Teams walks through this ownership matrix alongside tablet readiness, offline testing and pilot rollout as a single working document.